| WKN: | A0B9GA |
| ISIN: | CH0011432447 |
| Land: | Schweiz |
| Branche: | Chemie, Pharma, Bio- & Medizintechnik |
| Sektor: | Pharma |
Weshalb die Basilea Pharmaceutica-Aktie
ein C-Rating hat,
erfahren Sie im Performance-Check
vom 23. November 2025 Info.
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2013 | 36,96 | 86,00 | 132,72% |
| 2 | 2005 | 58,55 | 89,41 | 52,70% |
| 3 | 2006 | 89,41 | 132,33 | 48,00% |
| 4 | 2012 | 29,41 | 36,96 | 25,66% |
| 5 | 2019 | 35,46 | 43,11 | 21,57% |
| 6 | 2010 | 43,46 | 51,98 | 19,62% |
| 7 | 2022 | 39,49 | 46,38 | 17,45% |
| 8 | 2024 | 37,97 | 44,06 | 16,06% |
| 9 | 2025 | 44,06 | 51,10 | 15,97% |
| 10 | 2015 | 76,64 | 88,56 | 15,55% |
| 11 | 2020 | 43,11 | 49,14 | 13,99% |
| 12 | 2007 | 132,33 | 133,22 | 0,67% |
| 13 | 2017 | 68,19 | 64,87 | -4,88% |
| 14 | 2014 | 86,00 | 76,64 | -10,89% |
| 15 | 2023 | 46,38 | 37,97 | -18,14% |
| 16 | 2021 | 49,14 | 39,49 | -19,64% |
| 17 | 2016 | 88,56 | 68,19 | -23,00% |
| 18 | 2008 | 133,22 | 100,64 | -24,46% |
| 19 | 2011 | 51,98 | 29,41 | -43,42% |
| 20 | 2018 | 64,87 | 35,46 | -45,33% |
| Rang | Datum | Vorjahr | Schluss | Performance |
|---|---|---|---|---|
| 1 | 2009 | 100,64 | 43,46 | -56,82% |
| 2 | 2018 | 64,87 | 35,46 | -45,33% |
| 3 | 2011 | 51,98 | 29,41 | -43,42% |
| 4 | 2008 | 133,22 | 100,64 | -24,46% |
| 5 | 2016 | 88,56 | 68,19 | -23,00% |
| 6 | 2021 | 49,14 | 39,49 | -19,64% |
| 7 | 2023 | 46,38 | 37,97 | -18,14% |
| 8 | 2014 | 86,00 | 76,64 | -10,89% |
| 9 | 2017 | 68,19 | 64,87 | -4,88% |
| 10 | 2007 | 132,33 | 133,22 | 0,67% |
| 11 | 2020 | 43,11 | 49,14 | 13,99% |
| 12 | 2015 | 76,64 | 88,56 | 15,55% |
| 13 | 2025 | 44,06 | 51,10 | 15,97% |
| 14 | 2024 | 37,97 | 44,06 | 16,06% |
| 15 | 2022 | 39,49 | 46,38 | 17,45% |
| 16 | 2010 | 43,46 | 51,98 | 19,62% |
| 17 | 2019 | 35,46 | 43,11 | 21,57% |
| 18 | 2012 | 29,41 | 36,96 | 25,66% |
| 19 | 2006 | 89,41 | 132,33 | 48,00% |
| 20 | 2005 | 58,55 | 89,41 | 52,70% |